Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2

Saved in:
Bibliographic Details
Published in:J Immunother Cancer
Main Authors: Wong, Michael KK, Morse, Michael A, McDermott, David F, Clark, Joseph I, Kaufman, Howard L, Daniels, Gregory A, Perritt, Jessica C, Hua, Hong, Aung, Sandra
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Poster Presentation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4649297/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-3-S2-P359
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items